a decreasing trendp ≤ 0.05
A decreasing trend was observed in the case of colistin, which was statistically significant ( p ≤ 0.05) in 2023 (53/180; 29.44%) compared to 2022 (25/56; 44.64%) ( Figure 6 ).
A decreasing trend was observed in the case of colistin, which was statistically significant ( p ≤ 0.05) in 2023 (53/180; 29.44%) compared to 2022 (25/56; 44.64%) ( Figure 6 ).
The rates of blood and respiratory tract cultures showed an increasing trend in 2024, but it was without statistical significance ( Figure 1 ).